Consider a Fixed Dose of Rasburicase for Tumor Lysis Syndrome

December 2017

We're getting questions about rasburicase (Elitek) and other treatments for tumor lysis syndrome (TLS)...a common oncological emergency.

When dying cancer cells spill their contents, it can cause high levels of potassium, phosphorus, and uric acid...plus low calcium.

Consider patients to have active TLS when at least two of these lab abnormalities are present just before or after cancer treatment.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote